Recursion Pharmaceuticals, Inc.
RXRX
Revenue
14.42M
▲623.00k▲4.52%
3 Months ChangeAssets
775.86M
▲218.01M▲39.08%
3 Months ChangeLiabilities
191.41M
▲34.72M▲22.16%
3 Months ChangeFree Cash Flow
-108.95M
▼-30.46M▼-38.81%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-02
Form 8-K
ID: 0001601830-24-000165
2024-09-03
Form 8-K
ID: 0001601830-24-000148
2024-08-28
Form 8-K
ID: 0001601830-24-000140
2024-08-08
Form 10-Q
ID: 0001601830-24-000115
2024-08-08
Form 8-K
ID: 0001193125-24-196505
2024-08-06
Form 8-K
ID: 0001601830-24-000110
2024-06-27
Form 8-K
ID: 0001601830-24-000091
2024-06-24
Form 8-K
ID: 0001601830-24-000085
2024-06-07
Form 8-K
ID: 0001601830-24-000076
2024-05-24
Form 8-K
ID: 0001601830-24-000065